Connected Diabetes Care Innovations and Growth Opportunity Analysis 2024: Funding, Emerging Digital Diabetes Care Technologies, and Partnerships Shaping the Future of Global Diabetes Care
August 15, 2024 06:28 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Connected Diabetes Care: Innovations and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research provides...
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
August 08, 2024 08:00 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
July 30, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
[Latest] US Diabetes Devices Market Size/Share Worth USD 19.8 Billion by 2033 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 23, 2024 13:30 ET
|
Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Diabetes Devices Market Size, Trends and Insights By Type (Blood Glucose...
Italian Home/Self Testing Coagulation Market Research 2024: Diabetes, Pregnancy, Ovulation, Occult Blood Sales Forecasts, Technology Trends, and Competitive Strategies
July 22, 2024 05:47 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood-- Sales Forecasts, Technology Trends, Competitive Strategies" report has...
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
July 16, 2024 08:30 ET
|
Biodexa Pharmaceuticals PLC
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage...
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve Health & Wellness Outcomes
June 27, 2024 08:27 ET
|
Aeroflow Health
With Aeroflow Nutrition Services, patients receive a transparent, compassionate customer experience from a Registered Dietitian.
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
June 25, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care
June 24, 2024 10:48 ET
|
Cardiometabolic Health Congress
Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) -- The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care. The event will be held June...
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
June 24, 2024 06:30 ET
|
Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir